Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2021-10-12
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China
NCT03044847
Associations Between Air Pollutants Exposures and Respiratory System Study
NCT02964117
Small Bioactive Molecules in Early COPD Diseases
NCT04950023
Lung Health of Early COPD: A Multi-center Cohort Study
NCT05466396
Clinical Characteristics and Outcome of Patients With COPD With Pneumonia
NCT04966026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Air pollutants
Particulate matter and gaseous pollutants
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 40 to 80 years
* lived in Beijing for over one year before being recruited
* Agree to participate and sign the informed consent form.
Exclusion Criteria
* Patients with other respiratory diseases such as bronchiectasis and asthma.
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Furong Deng
Deputy Director of Department of Occupational and Environmental Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Furong Deng, Doctor
Role: PRINCIPAL_INVESTIGATOR
Peking University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University
Beijing, China, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang W, Chen B, Shima M, Zhao C, Guo L, Yoda Y, Li S, Wu S, Chen Y, Guo X, Deng F. PM2.5 as a risk factor for sleep oxygen desaturation in COPD: identifying susceptible individuals by smoking and inflammatory phenotypes. Thorax. 2025 Sep 15;80(10):683-692. doi: 10.1136/thorax-2025-223140.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00001052-21085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.